Elevance Health (ELV) Gains from Investment Securities (2009 - 2026)

Elevance Health (ELV) has 18 years of Gains from Investment Securities data on file, last reported at $34.0 million in Q1 2026.

• Quarterly Gains from Investment Securities fell 72.36% year-over-year to $34.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$57.0 million (down 128.08% YoY) and the FY2025 annual result came in at $32.0 million, down 70.64% from the prior year.
• Gains from Investment Securities improved to $34.0 million in Q1 2026 per ELV's latest filing, from $1.0 million in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $123.0 million in Q1 2025 and bottomed at -$85.0 million in Q2 2025.
• The 5-year median for Gains from Investment Securities is $28.5 million (2022), against an average of $24.6 million.
• Peak annual rise in Gains from Investment Securities reached 473.33% in 2022, while the deepest fall reached 300.0% in 2022.
• Tracing ELV's Gains from Investment Securities over 5 years: stood at $29.0 million in 2022, then surged by 82.76% to $53.0 million in 2023, then sank by 75.47% to $13.0 million in 2024, then sank by 92.31% to $1.0 million in 2025, then soared by 3300.0% to $34.0 million in 2026.
• Per Business Quant, the three latest ELV Gains from Investment Securities figures stand at $34.0 million (Q1 2026), $1.0 million (Q4 2025), and -$7.0 million (Q3 2025).

Peer Comparison